Their scientific methods may have been quite different, but their conclusions were not. In asking whether drug resistance could be a problem if antiretroviral (ARV) drugs become a mainstay for HIV prevention, two studies -- one involving a mathematical model and the other assays of cells and tissue -- arrived at the same answer. Resistance could happen if people who are unknowingly already infected use the approach.